-

PerkinElmer to Present at J.P. Morgan Healthcare Conference

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 at 7:30 a.m. ET.

Prahlad Singh, president and chief executive officer of PerkinElmer, will provide an update on the Company and its strategic priorities.

A live audio webcast will be available on the Investors section of the Company’s website at www.perkinelmer.com. A replay of the presentation will be posted on the PerkinElmer website after the event and will be available for 90 days following.

About PerkinElmer

PerkinElmer, Inc. is a global leader focused on innovating for a healthier world. The Company reported revenue of approximately $2.9 billion in 2019, has about 14,000 employees serving customers in 190 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.

Contacts

Investor Relations:
Bryan Kipp
+1-781-663-5583
Bryan.Kipp@perkinelmer.com

Media Relations:
Chet Murray
+1-781-663-5719
Chet.Murray@perkinelmer.com

Industry:

PerkinElmer, Inc.

NYSE:PKI
Release Versions
English

Contacts

Investor Relations:
Bryan Kipp
+1-781-663-5583
Bryan.Kipp@perkinelmer.com

Media Relations:
Chet Murray
+1-781-663-5719
Chet.Murray@perkinelmer.com

More News From PerkinElmer, Inc.

PerkinElmer Launches Cloud Based Solution to Enable Remote Lab Management

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of its PKeye™ Workflow Monitor, a cloud-based platform enabling laboratory personnel to remotely manage and monitor their PerkinElmer instruments and workflows in real-time. The PKeye Workflow Monitor offers scientists and researchers 24/7 access and visibility into their laboratory operations. With a cloud-based web design and centralized summary dashboa...

PerkinElmer Releases 2021 Corporate Social Responsibility Report

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader innovating for a healthier world, today released its 2021 Corporate Social Responsibility (CSR) Report, which summarizes the latest achievements of its environmental, social and governance (ESG) program. The report titled, “Strengthening Our Commitments for Sustainable Impact,” also outlines four new ESG commitments unveiled by the Company earlier this year and describes its reporting framework established in accord...

PerkinElmer Receives FDA Emergency Use Authorization for Respiratory SARS-CoV-2 Panel

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI) announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel 1 assay. Qualified laboratories can immediately begin using this single test for the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus (RSV) isolated from nasopharyngeal swabs, anterior nasal swabs...
Back to Newsroom